Influenza Myocarditis and Myositis: Case Presentation and Review of the Literature

Canadian Journal of Cardiology

Volumn 27, Issue 4, 2011, Pages 514-522

  Kumar, Kanwal ^a,b   Guirgis, Mina ^a   Zieroth, Shelley ^b   Lo, Evelyn ^b   Menkis, Alan H ^a   Arora, Rakesh C ^a,b   Freed, Darren H ^a,b  

^a St Boniface Research Centre   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

2009 H1N1 INFLUENZA; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EXTRACORPOREAL CIRCULATION; FASCIOTOMY; HUMAN; INFLUENZA MYOCARDITIS; INFLUENZA VIRUS A H1N1; MYOSITIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SHOCK; VIRULENCE; VIRUS MYOCARDITIS; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEART-ASSIST DEVICES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDITIS; MYOSITIS; PANDEMICS; YOUNG ADULT;

EID: 80052421031     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.03.005     Document Type: Review

References (72)

1. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005, 5:718-725.
2. Centers for Disease Control and Prevention Accessed October 2010. http://www.cdc.gov/flu/weekly/.
3. Khan K., Arino J., Hu W., et al. Spread of a novel influenza A (H1N1) virus via global airline transportation. N Engl J Med 2009, 361:212-214.
4. Cooper L.T. Myocarditis. N Engl J Med 2009, 360:1526-1538.
5. Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003, 42:466-472.
6. Kuhl U., Pauschinger M., Noutsias M., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005, 111:887-893.
7. Cooper L.T. Giant cell and granulomatous myocarditis. Heart Fail Clin 2005, 1:431-437.
8. Allanore Y., Vignaux O., Arnaud L., et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 2006, 65:249-252.
9. Ben m'rad M., Leclerc-Mercier S., Blanche P., et al. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 2009, 88:131-140.
10. Taliercio C.P., Olney B.A., Lie J.T. Myocarditis related to drug hypersensitivity. Mayo Clin Proc 1985, 60:463-468.
11. Hufnagel G., Pankuweit S., Richter A., et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000, 25:279-285.
12. Smith S.C., Ladenson J.H., Mason J.W., et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997, 95:163-168.
13. Morgera T., Di Lenarda A., Dreas L., et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J 1992, 124:455-467.
14. Shah A. Myocarditis masquerading as a ST elevation myocardial infarction (STEMI). South Med J 2010, 103:936-939.
15. Dec G.W., Waldman H., Southern J., et al. Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 1992, 20:85-89.
16. Sarda L., Colin P., Boccara F., et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 2001, 37:786-792.
17. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258.
18. Howlett J.G., McKelvie R.S., Arnold J.M., et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009, 25:85-105.
19. Cooper L.T., Baughman K.L., Feldman A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007, 116:2216-2233.
20. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987, 1:3-14.
21. Wu L.A., Lapeyre A.C., Cooper L.T. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc 2001, 76:1030-1038.
22. Hauck A.J., Kearney D.L., Edwards W.D. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989, 64:1235-1245.
23. Fodili F., van Bommel E.F. Severe rhabdomyolysis and acute renal failure following recent coxsackie B virus infection. Neth J Med 2003, 61:177-179.
24. Nauss M.D., Schmidt E.L., Pancioli A.M. Viral myositis leading to rhabdomyolysis: a case report and literature review. Am J Emerg Med 2009, 27:372. e5-6.
25. Crennan J.M., Van Scoy R.E., McKenna C.H., et al. Echovirus polymyositis in patients with hypogammaglobulinemia. Failure of high-dose intravenous gammaglobulin therapy and review of the literature. Am J Med 1986, 81:35-42.
26. Johnson R.W., Williams F.M., Kazi S., et al. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 2003, 49:172-178.
27. Plotz P.H., Dalakas M., Leff R.L., et al. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989, 111:143-157.
28. Tanaka T., Takada T., Takagi D., et al. Acute renal failure due to rhabdomyolysis associated with echovirus 9 infection: a case report and review of literature. Jpn J Med 1989, 28:237-242.
29. 2008 May report of the Auditor General of Canada. Chapter 5-Surveillance of infectious diseases 2008, Office of the Auditor General, Public Health Agency of Canada, Auditor General's Office, Ottawa.
30. Garten R.J., Davis C.T., Russell C.A., et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
31. Schnitzler S.U., Schnitzler P. An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 2009, 39:279-292.
32. Fisman D.N., Savage R., Gubbay J., et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 2009, 361:2000-2001.
33. Hancock K., Veguilla V., Lu X., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
34. Ison M.G., Campbell V., Rembold C., et al. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis 2005, 40:415-422.
35. Warren-Gash C., Smeeth L., Hayward A.C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009, 9:601-610.
36. Rothberg M.B., Haessler S.D. Complications of seasonal and pandemic influenza. Crit Care Med 2010, 38(4 suppl):e91-e97.
37. Komai T., Nakazawa G., Asai S., et al. Fatal fulminant myocarditis associated with novel influenza A (H1N1) infection. Eur Heart J 2011, 32:283.
38. Al-Amoodi M., Rao K., Rao S., et al. Fulminant myocarditis due to H1N1 influenza. Circ Heart Fail 2010, 3:e7-e9.
39. Bratincsak A., El-Said H.G., Bradley J.S., et al. Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 2010, 55:928-929.
40. Naghibi M., Wijesinghe L., Richardson T. Compartment syndrome: an unusual complication of influenza A infection. Postgrad Med 2008, 120:28-31.
41. Agyeman P., Duppenthaler A., Heininger U., et al. Influenza-associated myositis in children. Infection 2004, 32:199-203.
42. McGovern P.C., Chambers S., Blumberg E.A., et al. Successful explantation of a ventricular assist device following fulminant influenza type A-associated myocarditis. J Heart Lung Transplant 2002, 21:290-293.
43. Miura M., Asaumi Y., Wada Y., et al. A case of influenza subtype A virus-induced fulminant myocarditis: an experience of percutaneous cardio-pulmonary support (PCPS) treatment and immunohistochemical analysis. Tohoku J Exp Med 2001, 195:11-19.
44. Onitsuka H., Imamura T., Miyamoto N., et al. Clinical manifestations of influenza A myocarditis during the influenza epidemic of winter 1998-1999. J Cardiol 2001, 37:315-323.
45. Nolte K.B., Alakija P., Oty G., et al. Influenza A virus infection complicated by fatal myocarditis. Am J Forensic Med Pathol 2000, 21:375-379.
46. Swaringen J.C., Seiler J.G., Bruce R.W. Influenza A induced rhabdomyolysis resulting in extensive compartment syndrome. Clin Orthop Relat Res 2000, 375:243-249.
47. Vilchez R.A., Fung J.J., Kusne S. Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation 2000, 70:543-545.
48. Yoshino M., Suzuki S., Adachi K., et al. High incidence of acute myositis with type A influenza virus infection in the elderly. Intern Med 2000, 39:431-432.
49. Ray C.G., Icenogle T.B., Minnich L.L., et al. The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis. J Infect Dis 1989, 159:829-836.
50. Proby C.M., Hackett D., Gupta S., et al. Acute myopericarditis in influenza A infection. Q J Med 1986, 60:887-892.
51. Engblom E., Ekfors T.O., Meurman O.H., et al. Fatal influenza A myocarditis with isolation of virus from the myocardium. Acta Med Scand 1983, 213:75-78.
52. Österlund P., Pirhonen J., Ikonen N., et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010, 84:1414-1422.
53. Chan M.C., Cheung C.Y., Chui W.H., et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005, 6:135.
54. Cheung C.Y., Poon L.L., Lau A.S., et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360:1831-1837.
55. de Jong M.D., Simmons C.P., Thanh T.T., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12:1203-1207.
56. Wong S.S., Yuen K.Y. Avian influenza virus infections in humans. Chest 2006, 129:156-168.
57. Kaiser L., Fritz R.S., Straus S.E., et al. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 2001, 64:262-268.
58. Takano T, Tajiri H, Kashiwagi Y, et al. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection. Eur J Clin Microbiol Infect Dis.
59. Turkoz A., Cigli A., But K., et al. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery. J Cardiothorac Vasc Anesth 2001, 15:603-610.
60. Fairweather D., Frisancho-Kiss S., Rose N.R. Viruses as adjuvants for autoimmunity: evidence from coxsackievirus-induced myocarditis. Rev Med Virol 2005, 15:17-27.
61. Huber S.A., Pfaeffle B. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol 1994, 68:5126-5132.
62. Nishikubo K., Imanaka-Yoshida K., Tamaki S., et al. Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun 2007, 29:146-153.
63. Liu W., Li W.M., Gao C., et al. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. J Autoimmun 2005, 25:258-263.
64. Rangachari M., Mauermann N., Marty R.R., et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006, 203:2009-2019.
65. Bigalke B., Schwimmbeck P.L., Haas C.S., et al. Effect of interleukin-15 on the course of myocarditis in coxsackievirus B3-infected BALB/c mice. Can J Cardiol 2009, 25:e248-e254.
66. Kumar A., Zarychanski R., Pinto R., et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
67. Acker M.A. Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg 2001, 71:S73-S76. discussion S82-5.
68. Pages O.N., Aubert S., Combes A., et al. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg 2009, 137:194-197.
69. Grinda J.M., Chevalier P., D'Attellis N., et al. Fulminant myocarditis in adults and children: bi-ventricular assist device for recovery. Eur J Cardiothorac Surg 2004, 26:1169-1173.
70. Duncan B.W., Bohn D.J., Atz A.M., et al. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001, 122:440-448.
71. Asaumi Y., Yasuda S., Morii I., et al. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J 2005, 26:2185-2192.
72. Chen Y.S., Yu H.Y., Huang S.C., et al. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first?. J Heart Lung Transplant 2005, 24:81-87.